QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

WRBY

QT59Warby Parker Inc.
NYSE·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
25.96
+1.74+7.18%
OverviewShort InterestFilings
WRBYQT59Warby Parker Inc.·NYSE
OverviewShort InterestFilings
25.96+7.18%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E2221.15EPS (ttm)0.01
Insider Own28.58%
Shs Outstand122.72M
Perf Week0.39%
Market Cap2.97BForward P/E40.73EPS next Y0.64Insider Trans-0.16%Shs Float-Perf Month1.76%
Enterprise Value2.92BPEG2.63EPS next Q0.13Inst Own-Short Float-Perf Quarter6.52%
Income1.49MP/S3.34EPS this Y4761.80%Inst Trans-Short Ratio-Perf Half Y-2.59%
Sales890.58MP/B7.96EPS next Y31.10%ROA0.18%Short Interest-Perf YTD19.14%
Book/sh3.06P/C28.22EPS next 5Y43.53%ROE0.37%52W High31.00 -16.26%Perf Year18.92%
Cash/sh2.35P/FCF76.40EPS past 3/5Y-ROIC-0.64%52W Low14.96 73.53%Perf 3Y-
Dividend Est.-EV/EBITDA54.10Sales past 3/5Y13.40% 17.22%Gross Margin53.41%Volatility4.38% 4.81%Perf 5Y-
Dividend TTM-EV/Sales3.28EPS Y/Y TTM258.82%Oper. Margin-0.69%ATR (14)1.84Perf 10Y-
Dividend Ex-Date-Quick Ratio2.03Sales Y/Y TTM15.43%Profit Margin0.15%RSI (14)53.92Recom2.60
Dividend Gr. 3/5Y-Current Ratio2.33EPS Q/Q0.00%SMA204.07%Beta2.05Target Price31.00
Payout0.00%Debt/Eq0.63Sales Q/Q8.04%SMA505.27%Rel Volume5.81Prev Close24.22
Employees2,218LT Debt/Eq0.55EarningsAug 06SMA2008.45%Avg Volume3.24MPrice25.96
IPO DateSep 29, 2021Option/ShortYes / YesEPS/Sales Surpr.9.09% 1.26%Net Debt/EBITDA-0.94Volume18,817,469Change7.18%
Analyst Ratings
DateActionAnalystRatingTarget
May-22-26ReiteratedChina Renaissance Securities (US) Inc.$30
May-08-26ReiteratedTelsey Advisory$32 → $33
May-08-26ReiteratedUBSNeutral$20 → $27
May-07-26ReiteratedBTIGBuy$32 → $34
Feb-25-26ReiteratedUBSNeutral$23 → $20
Dec-17-25ReiteratedTelsey Advisory$24 → $32
Dec-17-25ReiteratedRobert W. Baird$27 → $35
Dec-16-25ReiteratedPiper SandlerOverweight$25 → $32
Dec-12-25ReiteratedStifel Nicolaus$19 → $25
Dec-11-25ReiteratedBTIGBuy$32
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue890872771
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A415401344
Gross Profit476471427
Selling, General and Administrative Excl. Other477476440
Research and Development
000
Other Operating Expense4017
Operating Income-6-5-30
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-8-8-11
Net Income Before Taxes23-20
Income Taxes111
Consolidated Net Income12-20
Net Income From Continuing Operations12-20
Net Income12-20
EPS (Recurring)0.010.01-0.17
EPS (Basic, Before Extraordinaries)0.010.01-0.17
EPS (Diluted)0.010.01-0.17
EBITDA545326
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio2,596.001,663.36—
Price To Sales Ratio3.593.07—
Gross Margin53.4854.0155.38
Operating Margin-0.67-0.57-3.89
Net Margin0.110.23-2.59
Shares Outstanding123123120
Market Capitalization3,1932,680—
Operating Lease Expense
———
Insider Trading Volume
$27.58$24.30$21.02$17.75$14.47● Close Price0.00M2.97M5.94M8.91M11.88MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Moon Youngme EDirectorJun 12 '26Sale26.5310,000265,30026,061Jun 12 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerJun 02 '26Option Exercise0.00130,87803,001,214Jun 04 12:00 AM
Gilboa David AbrahamCo-Chief Executive OfficerJun 02 '26Option Exercise0.00130,87804,675,566Jun 04 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerMay 19 '26Sale30.0363,0401,893,09150,165May 21 12:00 AM
SINGER BRADLEY EDirectorMay 14 '26Sale29.014,833140,205100,000May 15 12:00 AM
SINGER BRADLEY EDirectorMay 13 '26Sale28.5120,167574,961104,833May 15 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 20 '26Sale25.0922,442563,07050,165Apr 20 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 17 '26Sale24.5675,2131,847,59250,165Apr 20 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 16 '26Sale24.082,34556,46850,165Apr 20 12:00 AM
Raider Jeffrey JacobDirectorMar 11 '26Sale25.4325,000635,750448,697Mar 13 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerMar 05 '26Option Exercise0.00116,23003,143,251Mar 06 12:00 AM
Gilboa David AbrahamCo-Chief Executive OfficerMar 05 '26Option Exercise0.00116,23004,654,563Mar 06 12:00 AM
SINGER BRADLEY EDirectorMar 04 '26Sale27.5315,793434,78116,026Mar 06 12:00 AM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 13 '26Sale29.9966019,79337,119Jan 15 12:00 AM
Gilboa David AbrahamCo-Chief Executive OfficerJan 13 '26Sale29.4680,0942,359,56937,247Jan 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR